{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:14:19Z","timestamp":1791288859211,"version":"4.3.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0124348","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T17:57:04Z","timestamp":1429639024000},"page":"e0124348","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":75,"title":["Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function"],"prefix":"10.1371","volume":"10","author":[{"given":"Patrizia","family":"Paganin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia Vita","family":"Fiscarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Tuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Chiancianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Dolce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Dalmastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"De Alessandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzina","family":"Lucidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Taccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Mengoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Bevivino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thoraxjnl-2011-200953","article-title":"Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study","volume":"67","author":"D Taylor-Robinson","year":"2012","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00166412","article-title":"on behalf of the ECFS Patient Registry Steering Group. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry","volume":"43","author":"E Kerem","year":"2014","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1378\/chest.126.2.412","article-title":"Lung function decline in cystic fibrosis patients and timing for lung transplantation referral","volume":"126","author":"DB Rosenbluth","year":"2004","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1164\/rccm.200909-1421OC","article-title":"Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation","volume":"182","author":"DB Sanders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2007.03.006","article-title":"Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis","volume":"151","author":"MW Konstan","year":"2007","journal-title":"J Pediatr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1378\/chest.113.5.1230","article-title":"Risk of death in cystic fibrosis patients with severely compromised lung function","volume":"113","author":"CE Milla","year":"1998","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/JCM.01650-10","article-title":"Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers","volume":"49","author":"FA Stressmann","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1586\/ers.11.76","article-title":"The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications","volume":"5","author":"YJ Huang","year":"2011","journal-title":"Expert Rev Respir Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/thoraxjnl-2014-205826","article-title":"Respiratory microbiota: addressing clinical questions, informing clinical practice","volume":"70","author":"GB Rogers","year":"2015","journal-title":"Thorax"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/JCM.01324-09","article-title":"Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling","volume":"48","author":"GB Rogers","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref11","first-page":"a009738","article-title":"The cystic fibrosis airway microbiome","volume":"3","author":"V Lynch S","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1038\/srep04345","article-title":"Modeling the impact of antibiotic exposure on human microbiota","volume":"4","author":"J Zhao","year":"2014","journal-title":"Sci Rep"},{"key":"ref13","first-page":"13","article-title":"Emerging cystic fibrosis pathogens and the microbiome","volume":"15","author":"E Mahenthiralingam","year":"2014","journal-title":"Paediatr Respir Rev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1513\/AnnalsATS.201211-107OC","article-title":"Changes in cystic fibrosis airway microbiota at pulmonary exacerbation","volume":"10","author":"LA Carmody","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/CMR.00036-10","article-title":"Clinical significance of microbial infection and adaptation in cystic fibrosis","volume":"24","author":"AR Hauser","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"ref16","first-page":"787","article-title":"The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis","volume":"10","author":"CD Sibley","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"PM Farrell","year":"2008","journal-title":"J Pediatr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcf.2004.12.002","article-title":"Heijerman H for the Consensus Committee. Standards of care for patients with cystic fibrosis: A European consensus","volume":"4","author":"E Kerem","year":"2005","journal-title":"J Cyst Fibros"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"PA Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"for the Pulmozyme Study Group. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"HJ Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"for the Cystic Fibrosis Inhaled Tobramycin Study Group. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis","volume":"340","author":"BW Ramsey","year":"1999","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"MR Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200708-1151OC","article-title":"Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis","volume":"177","author":"MM Tunney","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/514631","article-title":"Microbiology of sputum from patients at cystic fibrosis centers in the United States","volume":"27","author":"JL Burns","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1128\/JCM.00492-13","article-title":"Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry","volume":"51","author":"P Seng","year":"2013","journal-title":"J Clin Microbiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.jprot.2012.03.048","article-title":"MALDI-TOF MS proteomic phenotyping of filamentous and other fungi from clinical origin","volume":"75","author":"F Del Chierico","year":"2012","journal-title":"J Proteomics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1469-0691.2010.03236.x","article-title":"Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients","volume":"16","author":"F Bittar","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1128\/JCM.42.11.5176-5183.2004","article-title":"Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling","volume":"42","author":"GB Rogers","year":"2004","journal-title":"J Clin Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1758-2229.2012.00368.x","article-title":"Peak Studio: a tool for the visualization and analysis of fragment analysis files","volume":"4","author":"J McCafferty","year":"2012","journal-title":"Environ Microbiol Rep"},{"key":"ref30","article-title":"R Foundation for Statistical Computing","year":"2014"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00248-006-9106-0","article-title":"MiCA: a web-based tool for the analysis of microbial communities based on terminal-restriction fragment length polymorphisms of 16S and 18S rRNA genes","volume":"53","author":"C Shyu","year":"2007","journal-title":"Microb Ecol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1073\/pnas.1120577109","article-title":"Decade-long bacterial community dynamics in cystic fibrosis airways","volume":"109","author":"J Zhao","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ppul.21526","article-title":"Lung function decline from adolescence to young adulthood in cystic fibrosis","volume":"47","author":"SL Vandenbranden","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"M Cazzola","year":"2008","journal-title":"Eur Respir J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"<italic>Pseudomonas aeruginosa<\/italic> and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"J Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"Supply 1","key":"ref36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/676882","article-title":"Infection prevention and control guidelines for cystic fibrosis: 2013 update","volume":"35","author":"L Saiman","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/bmb\/ldn050","article-title":"Recent advances in the microbiology of respiratory tract infection in cystic fibrosis","volume":"89","author":"J Foweraker","year":"2009","journal-title":"Br Med Bull"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcf.2010.11.003","article-title":"Population structure and characterization of viridans group streptococci (VGS) including <italic>Streptococcus pneumoniae<\/italic> isolated from adult patients with cystic fibrosis (CF)","volume":"10","author":"Y Maeda","year":"2011","journal-title":"J Cyst Fibros"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e2908","DOI":"10.1371\/journal.pone.0002908","article-title":"Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients","volume":"3","author":"F Bittar","year":"2008","journal-title":"PLoS One. Public Library of Science"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ismej.2010.88","article-title":"Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis","volume":"5","author":"AM Guss","year":"2011","journal-title":"ISME J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e64285","DOI":"10.1371\/journal.pone.0064285","article-title":"Mechanistic model of <italic>Rothia mucilaginosa<\/italic> adaptation toward persistence in the CF lung, based on a genome reconstructed from metagenomic data","volume":"8","author":"YW Lim","year":"2013","journal-title":"PLoS One. Public Library of Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1378\/chest.09-2996","article-title":"Sputum <italic>Candida albicans<\/italic> presages FEV<sub>1<\/sub> decline and hospital-treated exacerbations in cystic fibrosis","volume":"138","author":"SH Chotirmall","year":"2010","journal-title":"Chest"},{"key":"ref43","first-page":"93","article-title":"The evolving polymicrobial composition in the airways of patients with cystic fibrosis: implications for disease progression and clinical management","volume":"3","author":"A Bevivino","year":"2013","journal-title":"CML Cystic Fibrosis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1128\/AEM.63.11.4516-4522.1997","article-title":"Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA","volume":"63","author":"WT Liu","year":"1997","journal-title":"Appl Environ Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1462-2920.2000.00081.x","article-title":"An evaluation of terminal-restriction fragment length polymorphism (T-RFLP) analysis for the study of microbial community structure and dynamics","volume":"2","author":"AM Osborn","year":"2000","journal-title":"Environ Microbiol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0076-6879(05)97018-3","article-title":"Culture-independent microbial community analysis with terminal restriction fragment length polymorphism","volume":"397","author":"TL Marsh","year":"2005","journal-title":"Methods Enzymol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-60761-439-5_6","article-title":"Using terminal restriction fragment length polymorphism (T-RFLP) analysis to assess microbial community structure in compost systems","volume":"599","author":"SM Tiquia","year":"2010","journal-title":"Methods Mol Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mimet.2010.01.025","article-title":"Monitoring of phytoplankton community structure using terminal restriction fragment length polymorphism (T-RFLP)","volume":"81","author":"S Joo","year":"2010","journal-title":"J Microbiol Methods"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00248-010-9703-9","article-title":"Prediction of plausible bacterial composition based on terminal restriction fragment length polymorphisms using a Monte Carlo method","volume":"60","author":"Y Nakano","year":"2010","journal-title":"Microb Ecol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/JCM.41.8.3548-3558.2003","article-title":"Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling","volume":"41","author":"GB Rogers","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"15070","DOI":"10.1073\/pnas.0804326105","article-title":"A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients","volume":"105","author":"CD Sibley","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1574-6941.2011.01197.x","article-title":"Validating T-RFLP as a sensitive and high-throughput approach to assess bacterial diversity patterns in human anterior nares","volume":"79","author":"A Camarinha-Silva","year":"2012","journal-title":"FEMS Microbiol Ecol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1128\/JB.00566-12","article-title":"Prevalence of Streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability","volume":"194","author":"LM Filkins","year":"2012","journal-title":"J Bacteriol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e53649","DOI":"10.1371\/journal.pone.0053649","article-title":"Biased diversity metrics revealed by bacterial 16S pyrotags derived from different primer sets","volume":"8","author":"L Cai","year":"2013","journal-title":"PLoS One. Public Library of Science"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/j.1365-294X.2012.05470.x","article-title":"Towards next-generation biodiversity assessment using DNA metabarcoding","volume":"21","author":"P Taberlet","year":"2012","journal-title":"Mol Ecol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e45791","DOI":"10.1371\/journal.pone.0045791","article-title":"Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions","volume":"7","author":"H Maughan","year":"2012","journal-title":"PLoS One. Public Library of Science"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/JCM.02204-13","article-title":"Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis","volume":"52","author":"YW Lim","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1128\/AEM.00514-07","article-title":"Interpreting ecological diversity indices applied to terminal restriction fragment length polymorphism data: insights from simulated microbial communities","volume":"73","author":"CB Blackwood","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-13-1","article-title":"Community terminal restriction fragment length polymorphisms reveal insights into the diversity and dynamics of leaf endophytic bacteria","volume":"13","author":"T Ding","year":"2013","journal-title":"BMC Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0124348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T04:27:25Z","timestamp":1598934445000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0124348"}},"subtitle":[],"editor":[{"given":"Dominik","family":"Hartl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0124348","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]}}}